David Larsen
Stock Analyst at BTIG
(0.13)
# 4,311
Out of 4,408 analysts
569
Total ratings
34.9%
Success rate
-5.7%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Upgraded: Buy | $100 | $81.07 | +23.35% | 14 | Jun 11, 2026 | |
| MDLN Medline | Reiterated: Buy | $55 | $37.33 | +47.33% | 5 | Jun 9, 2026 | |
| TOI The Oncology Institute | Maintained: Buy | $7 → $8 | $5.18 | +54.44% | 10 | Jun 8, 2026 | |
| VEEV Veeva Systems | Rated: Buy | $340 | $162.17 | +109.66% | 13 | Jun 3, 2026 | |
| ASTH Astrana Health | Rated: Buy | $40 → $50 | $38.37 | +30.33% | 14 | Jun 2, 2026 | |
| HQY HealthEquity | Maintained: Buy | $110 | $86.60 | +27.02% | 30 | May 28, 2026 | |
| DOCS Doximity | Downgraded: Hold | n/a | $20.62 | - | 12 | May 14, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | n/a | $1.82 | - | 25 | May 12, 2026 | |
| DCGO DocGo | Maintained: Hold | n/a | $0.5795 | - | 18 | May 12, 2026 | |
| PGNY Progyny | Maintained: Buy | $30 | $26.86 | +11.71% | 18 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.8031 | - | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $12 | $8.60 | +39.62% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.91 | +103.67% | 43 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $17 | $14.77 | +15.10% | 30 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.69 | - | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $65 | $63.97 | +1.62% | 16 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.47 | - | 19 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $39.99 | - | 25 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $30.17 | - | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $4.68 | +71.12% | 50 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $40 | $34.66 | +15.41% | 11 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $178.39 | - | 11 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.41 | - | 17 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.69 | - | 10 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $114.34 | - | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $22.99 | n/a | 15 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 16 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $281.43 | n/a | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $189.10 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $100.68 | n/a | 28 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $65 → $55 | $226.40 | n/a | 12 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $9 | $3.03 | n/a | 6 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $160 | $779.78 | n/a | 11 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $13 | $4.85 | n/a | 8 | Jun 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 → $25 | $26.13 | n/a | 5 | Nov 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | - | n/a | 3 | Nov 3, 2016 |
Henry Schein
Jun 11, 2026
Upgraded: Buy
Price Target: $100
Current: $81.07
Upside: +23.35%
Medline
Jun 9, 2026
Reiterated: Buy
Price Target: $55
Current: $37.33
Upside: +47.33%
The Oncology Institute
Jun 8, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $5.18
Upside: +54.44%
Veeva Systems
Jun 3, 2026
Rated: Buy
Price Target: $340
Current: $162.17
Upside: +109.66%
Astrana Health
Jun 2, 2026
Rated: Buy
Price Target: $40 → $50
Current: $38.37
Upside: +30.33%
HealthEquity
May 28, 2026
Maintained: Buy
Price Target: $110
Current: $86.60
Upside: +27.02%
Doximity
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $20.62
Upside: -
Health Catalyst
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $1.82
Upside: -
DocGo
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.5795
Upside: -
Progyny
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $26.86
Upside: +11.71%
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $0.8031
Upside: -
May 8, 2026
Maintained: Buy
Price Target: $11 → $12
Current: $8.60
Upside: +39.62%
May 7, 2026
Reiterated: Buy
Price Target: $10
Current: $4.91
Upside: +103.67%
May 5, 2026
Maintained: Buy
Price Target: $15 → $17
Current: $14.77
Upside: +15.10%
May 5, 2026
Maintained: Hold
Price Target: n/a
Current: $8.69
Upside: -
May 4, 2026
Maintained: Buy
Price Target: $55 → $65
Current: $63.97
Upside: +1.62%
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $7.47
Upside: -
Apr 28, 2026
Maintained: Hold
Price Target: n/a
Current: $39.99
Upside: -
Mar 5, 2026
Maintained: Hold
Price Target: n/a
Current: $30.17
Upside: -
Feb 25, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $4.68
Upside: +71.12%
Feb 17, 2026
Maintained: Buy
Price Target: $37 → $40
Current: $34.66
Upside: +15.41%
Feb 5, 2026
Maintained: Hold
Price Target: n/a
Current: $178.39
Upside: -
Jan 22, 2026
Maintained: Hold
Price Target: n/a
Current: $16.41
Upside: -
Nov 14, 2025
Rated: Hold
Price Target: n/a
Current: $11.69
Upside: -
Nov 4, 2025
Rated: Hold
Price Target: n/a
Current: $114.34
Upside: -
Mar 5, 2025
Maintained: Buy
Price Target: $35
Current: $22.99
Upside: n/a
Jun 23, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $281.43
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $189.10
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $100.68
Upside: n/a
Nov 16, 2018
Downgraded: Hold
Price Target: $65 → $55
Current: $226.40
Upside: n/a
Oct 31, 2018
Maintained: Hold
Price Target: $17 → $9
Current: $3.03
Upside: n/a
May 29, 2018
Reiterated: Hold
Price Target: $170 → $160
Current: $779.78
Upside: n/a
Jun 19, 2017
Downgraded: Hold
Price Target: $17 → $13
Current: $4.85
Upside: n/a
Nov 4, 2016
Maintained: Hold
Price Target: $26 → $25
Current: $26.13
Upside: n/a
Nov 3, 2016
Reiterated: Hold
Price Target: $9
Current: -
Upside: n/a